alto ingredients - ALTO

ALTO

Close Chg Chg %
2.72 -0.08 -2.94%

Open Market

2.64

-0.08 (2.94%)

Volume: 225.45K

Last Updated:

Jan 15, 2026, 11:47 AM EDT

Company Overview: alto ingredients - ALTO

ALTO Key Data

Open

$2.71

Day Range

2.60 - 2.75

52 Week Range

0.76 - 3.18

Market Cap

$210.37M

Shares Outstanding

77.34M

Public Float

67.50M

Beta

0.54

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.70

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.35M

 

ALTO Performance

1 Week
 
13.81%
 
1 Month
 
-8.11%
 
3 Months
 
151.85%
 
1 Year
 
47.03%
 
5 Years
 
-60.69%
 

ALTO Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 2
Full Ratings ➔

About alto ingredients - ALTO

Alto Ingredients, Inc. engages in the production and marketing of specialty alcohols and essential ingredients. It operates through the following segments: Marketing and Distribution, Pekin Production, and Western Production. The Marketing and Distribution segment includes marketing and merchant trading for company-produced alcohols and essential ingredients, on an aggregated basis, and third-party fuel-grade ethanol. The Pekin Campus Production segment deals with the production and sale of alcohols and essential ingredients produced at the company's Pekin, Illinois campus. The Western Production segment covers the production and sale of renewable fuel and essential ingredients produced at two western production facilities. The company was founded by William L. Jones and Neil M. Koehler on January 30, 2003, and is headquartered in Pekin, IL.

ALTO At a Glance

Alto Ingredients, Inc.
1300 South Second Street
Pekin, Illinois 61554
Phone 1-833-710-2586 Revenue 965.26M
Industry Chemicals: Specialty Net Income -58,984,000.00
Sector Process Industries Employees 393
Fiscal Year-end 12 / 2025
View SEC Filings

ALTO Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 0.119
Price to Book Ratio 0.531
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -29.032
Enterprise Value to Sales 0.20
Total Debt to Enterprise Value 0.594

ALTO Efficiency

Revenue/Employee 2,456,127.226
Income Per Employee -150,086.514
Receivables Turnover 16.58
Total Asset Turnover 2.229

ALTO Liquidity

Current Ratio 2.649
Quick Ratio 1.785
Cash Ratio 0.626

ALTO Profitability

Gross Margin -0.137
Operating Margin -3.218
Pretax Margin -6.093
Net Margin -6.111
Return on Assets -13.623
Return on Equity -23.378
Return on Total Capital -17.362
Return on Invested Capital -16.486

ALTO Capital Structure

Total Debt to Total Equity 50.949
Total Debt to Total Capital 33.753
Total Debt to Total Assets 28.45
Long-Term Debt to Equity 48.794
Long-Term Debt to Total Capital 32.325
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Alto Ingredients - ALTO

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
1.21B 1.34B 1.22B 965.26M
Sales Growth
+34.66% +10.57% -8.44% -21.07%
Cost of Goods Sold (COGS) incl D&A
1.16B 1.38B 1.20B 966.58M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
23.29M 25.09M 23.08M 24.41M
Depreciation
23.29M 24.53M 22.49M 23.82M
Amortization of Intangibles
- 567.00K 588.00K 588.00K
COGS Growth
+35.25% +19.00% -13.25% -19.40%
Gross Income
46.17M (46.81M) 23.68M (1.32M)
Gross Income Growth
+21.23% -201.40% +150.59% -105.59%
Gross Profit Margin
+3.82% -3.50% +1.94% -0.14%
2021 2022 2023 2024 5-year trend
SG&A Expense
29.18M 31.58M 32.66M 29.74M
Research & Development
- - - -
-
Other SG&A
29.18M 31.58M 32.66M 29.74M
SGA Growth
-8.74% +8.20% +3.44% -8.96%
Other Operating Expense
- - - -
-
Unusual Expense
4.24M 4.02M 16.22M 18.92M
EBIT after Unusual Expense
12.74M (82.41M) (25.20M) (49.98M)
Non Operating Income/Expense
38.40M 44.56M 4.72M (1.19M)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
3.59M 1.83M 7.42M 7.64M
Interest Expense Growth
-80.01% -49.07% +306.40% +2.95%
Gross Interest Expense
3.59M 1.83M 7.42M 7.64M
Interest Capitalized
- - - -
-
Pretax Income
47.55M (39.67M) (27.91M) (58.81M)
Pretax Income Growth
+374.88% -183.43% +29.65% -110.73%
Pretax Margin
+3.94% -2.97% -2.28% -6.09%
Income Tax
1.47M 1.93M 97.00K 173.00K
Income Tax - Current - Domestic
1.47M 1.93M 97.00K 173.00K
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - (600.00K)
-
Consolidated Net Income
45.48M (41.60M) (28.00M) (58.98M)
Minority Interest Expense
- - - -
-
Net Income
45.48M (41.60M) (28.00M) (58.98M)
Net Income Growth
+400.89% -191.46% +32.68% -110.62%
Net Margin Growth
+3.77% -3.11% -2.29% -6.11%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
45.48M (41.60M) (28.00M) (58.98M)
Preferred Dividends
1.26M 1.26M 1.26M 1.27M
Net Income Available to Common
44.22M (42.86M) (29.27M) (60.25M)
EPS (Basic)
0.6219 -0.5958 -0.3991 -0.82
EPS (Basic) Growth
+322.42% -195.80% +33.01% -105.46%
Basic Shares Outstanding
71.10M 71.94M 73.34M 73.48M
EPS (Diluted)
0.6123 -0.5958 -0.3991 -0.82
EPS (Diluted) Growth
+318.99% -197.31% +33.01% -105.46%
Diluted Shares Outstanding
72.22M 71.94M 73.34M 73.48M
EBITDA
40.27M (53.30M) 14.10M (6.65M)
EBITDA Growth
+10.74% -232.34% +126.46% -147.17%
EBITDA Margin
+3.33% -3.99% +1.15% -0.69%

Snapshot

Average Recommendation BUY Average Target Price 4.00
Number of Ratings 2 Current Quarters Estimate -0.12
FY Report Date 03 / 2026 Current Year's Estimate -0.045
Last Quarter’s Earnings -0.02 Median PE on CY Estimate N/A
Year Ago Earnings -0.14 Next Fiscal Year Estimate N/A
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 1 1 2 N/A
Mean Estimate -0.12 -0.05 -0.05 N/A
High Estimates -0.12 -0.05 0.16 N/A
Low Estimate -0.12 -0.05 -0.25 N/A
Coefficient of Variance N/A N/A -644.25 N/A

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 2 2 2
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Alto Ingredients - ALTO

Date Name Shares Transaction Value
Apr 4, 2025 James R. Sneed Chief Commercial Officer 429,221 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Bryon T. McGregor President & CEO; Director 989,765 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Bryon T. McGregor President & CEO; Director 930,836 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $1.12 per share 1,042,536.32
Apr 4, 2025 Auste Maria Graham CLO & Secretary 277,958 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Auste Maria Graham CLO & Secretary 255,281 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $1.12 per share 285,914.72
Apr 4, 2025 Robert R. Olander Chief Financial Officer 280,556 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Robert R. Olander Chief Financial Officer 258,428 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $1.12 per share 289,439.36
Apr 4, 2025 Todd E. Benton COO 189,112 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Todd E. Benton COO 173,759 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $1.12 per share 194,610.08

Alto Ingredients in the News